Vimarsana
Biggest News Aggregation in the World

Page 9 - Safety Update News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Safety Update. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Safety Update Today - Breaking & Trending Today

REGENXBIO Presents Positive Initial Data from Phase I/II Trial of RGX-111 for the Treatment of Severe MPS I at 18th Annual WORLDSymposium™ 2022 - Vimarsana News

REGENXBIO Presents Positive Initial Data from Phase I/II Trial of RGX-111 for the Treatment of Severe MPS I at 18th Annual WORLDSymposium™ 2022

/PRNewswire/ -- RGX-111, a potential one-time gene therapy for MPS I, is well-tolerated across two dose levels, with no drug-related serious adverse events...

REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at 18th Annual WORLDSymposium™ 2022 - Vimarsana News

REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at 18th Annual WORLDSymposium™ 2022

/PRNewswire/ -- RGX-121, a one-time gene therapy for MPS II, continues to be well-tolerated with no drug-related SAEs across three dose levels Dose-dependent...

MEAN GIRLS National Tour is Coming to Portland's Keller Auditorium This November - Vimarsana News

MEAN GIRLS National Tour is Coming to Portland's Keller Auditorium This November

Broadway in Portland has announced the First National Tour of Mean Girls—the record-breaking new musical comedy based on the hit film—will be coming to Keller Auditorium from Wednesday, November 10 through Sunday, November 14 as part of the 2021-2022 Broadway Season. 

Drug Safety Update: monthly PDF newsletter - Vimarsana News

Drug Safety Update: monthly PDF newsletter

Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor the Commission on Human Medicines.

Source: gov.uk
New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ® (upadacitinib) in Patients with Rheumatoid Arthritis to be Presented at EULAR 2021 Virtual Congress - Vimarsana News

New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ® (upadacitinib) in Patients with Rheumatoid Arthritis to be Presented at EULAR 2021 Virtual Congress

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new analyses to be presented at the EULAR 2021 Virtual Congress showing patients with moderate to severe...